Archive - January 2018
Data Points: The lifetime cost of diabetes
Viral Tide Pod challenge has serious health consequences
CVS vows to stop touching up its beauty images
Cover: Jan. 29, 2018
Bundled payment success varies by condition
FDA Accepts Biologics License Application for Fremanezumab with Priority Review for Prevention of Migraine and Grants Fast Track Designation for Cluster Headache Development Program
TherapeuticsMD Announces FDA Acceptance of New Drug Application and Prescription Drug User Fee Act (PDUFA) Date for TX-004HR
FDA Accepts New Drug Application for Seysara (sarecycline) for the Treatment of Moderate to Severe Acne